Ilustração: Marta Pucci

DIU: o que é, mitos, como é inserido e funcionamento

Saiba tudo sobre um dos métodos mais eficazes para evitar gravidez

por Giordana Braga

Actualizado: Apr 3, 2019
Publicado: Apr 3, 2019

— Actualizado: Apr 3, 2019 | Publicado: Apr 3, 2019

Revisado médicamente por Laurie Ray, DNP

Sincronízate con tu ciclo y descarga la aplicación de Clue hoy.

Apple Store

Google Play

Referencias

Trussell J. Contraceptive failure in the United States. Contraception. 2011 May;83(5):397–404.
Ministério da Saúde do Brasil. Pesquisa Nacional de Demografia e Saúde da criança e da Mulher - PNDS 2006. Available from: bvsms.saude.gov.br/bvs/publicacoes/pnds_crianca_mulher.pdf
Buhling KJ, Hauck B, Dermout S, Ardaens K, Marions L. Understanding the barriers and myths limiting the use of intrauterine contraception in nulliparous women: results of a survey of European/Canadian healthcare providers. Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:146–54.
Buhling KJ, Lotke P, Black K, INTRA Writing Group. Worldwide use of intrauterine contraception: a review. Contraception 2014 ;89(3):162-73.
Silva-Filho AL, Lira J, Rocha AL, Ferreira MC, Lamaita RM, Candido EB, CArneiro MM. Non-hormonal and hormonal intrauterine contraception: survey of patients’ perceptions in four Latin American countries.European Journal of Reproductive Health Care, 2016;21(3):213-9.
Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007 Jun;75(6 Suppl):S16-30.
Wildemeersch D. Commentary - Lyus R, Lohr P, Prager S. Use of Mirena LNG-IUS and Paragard CuT380A intrauterine devices for nulliparous women [Contraception 2010;81:367-371]. Contraception. 2011 Feb;83(2):184-186-187.
WHO elegibility criteria for contraceptive use, 5th edition, 2015.
Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception. 2011 Nov;84(5):e11-16.
Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet Lond Engl. 1992 Mar 28;339(8796):785–8.
Black KI, Lotke P, Lira J, Peers T, Zite NB. Global survey of healthcare practitioners’ beliefs and practices around intrauterine contraceptive method use in nulliparous women. Contraception. 2013 Nov;88(5):650–6.
Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S, et al. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Hum Reprod Oxf Engl. 2015 Nov;30(11):2527–38.
Jensen J, Mansour D, Lukkari-Lax E, Inki P, Burock K, Fraser IS. Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Contraception. 2013 Jan;87(1):107–12.
Bosanac SS, Trivedi M, Clark AK, Sivamani RK, Larsen LN. Progestins and acne vulgaris: a review. Dermmaology Online Journal. 2018 15;24(5).

DIU: o que é, mitos, como é inserido e funcionamento

Saiba tudo sobre um dos métodos mais eficazes para evitar gravidez

Sincronízate con tu ciclo y descarga la aplicación de Clue hoy.

¿Fue útil este artículo?

También te podría gustar leer:

La ciencia detrás de la menstruación y el género

Sincronízate con tu ciclo y descarga la aplicación de Clue hoy.